Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy
Joseph J. Safdieh, David Schwartz, Joseph Weiner, Jeffrey P. Weiss, Justin Rineer, Isaac Madeb, Marvin Rotman, David Schreiber
Radiat Oncol J. 2014;32(3):179-186.   Published online 2014 Sep 30     DOI: https://doi.org/10.3857/roj.2014.32.3.179
Citations to this article as recorded by Crossref logo
Kidney Graft Urothelial Carcinoma: Results From a Multicentric Retrospective National Study
Grégoire Leon, Nicolas Szabla, Romain Boissier, Marc Gigante, Kevin Caillet, Gregory Verhoest, Xavier Tillou
Urology.2020; 135: 101.     CrossRef
Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
Р. V. Bulychkin, S. I. Tkachev, V. B. Matveev, A. V. Nazarenko
Cancer Urology.2019; 15(2): 66.     CrossRef
Complications des traitements multimodaux
C. Hennequin
Progrès en Urologie.2019; 29: S35.     CrossRef
Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy
Tairo Kashihara, Satoshi Nakamura, Akihisa Wakita, Hiroyuki Okamoto, Koji Inaba, Rei Umezawa, Satoshi Shima, Keisuke Tsuchida, Kazuma Kobayashi, Kana Takahashi, Naoya Murakami, Yoshinori Ito, Hiroshi Igaki, Hiroyuki Fujimoto, Takashi Uno, Jun Itami
Cancer Medicine.2018; 7(5): 1723.     CrossRef
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer
Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, Christopher C. Parker, Paul L. Nguyen, Andrew J. Stephenson, Christian Carrie
European Urology Oncology.2018; 1(1): 3.     CrossRef
Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort
Andrew T. Wong, David Schwartz, Anna Lee, Joseph Safdieh, Virginia Osborn, David Schreiber
Clinical Genitourinary Cancer.2017; 15(1): 168.     CrossRef
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
Miguel Reis Ferreira, Atia Khan, Karen Thomas, Lesley Truelove, Helen McNair, Annie Gao, Chris C. Parker, Robert Huddart, Margaret Bidmead, Ros Eeles, Vincent Khoo, Nicholas J. van As, Vibeke N. Hansen, David P. Dearnaley
International Journal of Radiation Oncology*Biology*Physics.2017; 99(5): 1234.     CrossRef
Radiotherapy after prostatectomy: prognosis, timing and outcomes
Anna Wilson
British Journal of Nursing.2016; 25(18): S4.     CrossRef
Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
Xiaofang Wang, Wenjuan Zhang, Zi Yan, Yupei Liang, Lihui Li, Xiaoli Yu, Yan Feng, Shen Fu, Yanmei Zhang, Hu Zhao, Jinha Yu, Lak Shin Jeong, Xiaomao Guo, Lijun Jia
Oncotarget.2016; 7(25): 38380.     CrossRef
Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer
David Schreiber, Justin Rineer, Jeffrey P. Weiss, Joseph Safdieh, Joseph Weiner, Marvin Rotman, David Schwartz
Radiation Oncology Journal.2015; 33(1): 21.     CrossRef